Finland Views

Pages

Lundbeck launches Selincro in Europe

Lundbeck has shipped Selincro (nalmefene) in its first markets and made the product available for alcohol dependent patients with high-risk drinking levels (>60g/day for men, >40g/day for women)...

Read article ›
Drug Approvals Rate Remains High

BMI View: While the approval rate for medicines in Finland has remained high in recent years, BMI believes that drugmakers may be faced with an increasingly tough medicines approvals environment in...

Read article ›
Industry Trends & Developments

In November 2012 FICORA opened the registration process for the 800MHz spectrum auction, which will begin in late January 2013. Registrations were open until December 17 2012. The regulator is set to...

Read article ›

Pages